Pages that link to "Q44959762"

The following pages link to Levosimendan interacts with potassium channel blockers in human saphenous veins (Q44959762):

Displaying 15 items.

• Levosimendan and its metabolite OR-1896 elicit KATP channel-dependent dilation in resistance arteries in vivo (Q33863590) (← links)
• The levosimendan metabolite OR-1896 elicits vasodilation by activating the K(ATP) and BK(Ca) channels in rat isolated arterioles (Q35546222) (← links)
• Pharmacological mechanisms contributing to the clinical efficacy of levosimendan (Q36114364) (← links)
• The role of venodilators in the perioperative management of heart failure (Q37978459) (← links)
• Inotropes and inodilators for acute heart failure: sarcomere active drugs in focus (Q38208442) (← links)
• Levosimendan induces NO production through p38 MAPK, ERK and Akt in porcine coronary endothelial cells: role for mitochondrial K(ATP) channel (Q41413471) (← links)
• Letter regarding levosimendan in a rat model of severe verapamil poisoning (Q42873243) (← links)
• Comparison of the effects of levosimendan and papaverine on human internal mammary artery and saphenous vein (Q43261914) (← links)
• Role of potassium channels in the relaxant effect of levosimendan in guinea pig tracheal preparations (Q44786712) (← links)
• First experiences with intraoperative Levosimendan in pediatric cardiac surgery (Q46132536) (← links)
• The clinical effects of levosimendan are not attenuated by sulfonylureas (Q47212291) (← links)
• Effect of levosimendan on ventriculo-arterial coupling in patients with ischemic cardiomyopathy (Q48564458) (← links)
• The gender differences in the relaxation to levosimendan of human internal mammary artery (Q51741664) (← links)
• Use of Levosimendan in Intensive Care Unit Settings: An Opinion Paper (Q60950194) (← links)
• Use of levosimendan in acute and advanced heart failure: short review on available real-world data (Q92236838) (← links)